Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
KMDA similar filings
- 24 May 23 Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates
- 24 May 23 Report of Foreign Private Issuer
- 24 May 23 Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds
- 17 May 23 Report of Foreign Private Issuer
- 16 May 23 Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland
- 3 May 23 Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company’s Facility in Israel
- 15 Mar 23 Kamada Issues 2023 CEO Letter to Shareholders
Filing view
External links